162 related articles for article (PubMed ID: 16302325)
41. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris.
Shalita AR; Myers JA; Krochmal L; Yaroshinsky A;
J Drugs Dermatol; 2005; 4(1):48-56. PubMed ID: 15696985
[TBL] [Abstract][Full Text] [Related]
42. Clinical efficacy of Velac, a new tretinoin and clindamycin phosphate gel in acne vulgaris.
Cambazard F
J Eur Acad Dermatol Venereol; 1998 Sep; 11 Suppl 1():S20-7; discussion S28-9. PubMed ID: 9891905
[TBL] [Abstract][Full Text] [Related]
43. A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide.
Thiboutot D; Eichenfield L; Shalita A; Del Rosso JQ; Swinyer L; Tanghetti E; Tschen E; Parr L
Cutis; 2009 Jul; 84(1):48-55. PubMed ID: 19743725
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial.
Prasad S; Mukhopadhyay A; Kubavat A; Kelkar A; Modi A; Swarnkar B; Bajaj B; Vedamurthy M; Sheikh S; Mittal R
Indian J Dermatol Venereol Leprol; 2012; 78(4):459-67. PubMed ID: 22772617
[TBL] [Abstract][Full Text] [Related]
45. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%.
Zhang JZ; Li LF; Tu YT; Zheng J
J Dermatolog Treat; 2004 Dec; 15(6):372-8. PubMed ID: 15764049
[TBL] [Abstract][Full Text] [Related]
46. Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.
Amar L; Kircik LH
J Drugs Dermatol; 2018 Oct; 17(10):1107-1112. PubMed ID: 30365592
[TBL] [Abstract][Full Text] [Related]
47. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
Tanghetti E; Dhawan S; Torok H; Kircik L
Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
[TBL] [Abstract][Full Text] [Related]
48. Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
Guerra-Tapia A
J Drugs Dermatol; 2012 Jun; 11(6):714-22. PubMed ID: 22648218
[TBL] [Abstract][Full Text] [Related]
49. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
Bowman S; Gold M; Nasir A; Vamvakias G
J Drugs Dermatol; 2005; 4(5):611-8. PubMed ID: 16167420
[TBL] [Abstract][Full Text] [Related]
50. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations.
Lookingbill DP; Chalker DK; Lindholm JS; Katz HI; Kempers SE; Huerter CJ; Swinehart JM; Schelling DJ; Klauda HC
J Am Acad Dermatol; 1997 Oct; 37(4):590-5. PubMed ID: 9344199
[TBL] [Abstract][Full Text] [Related]
51. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris.
Pariser DM; Rich P; Cook-Bolden FE; Korotzer A
J Drugs Dermatol; 2014 Sep; 13(9):1083-9. PubMed ID: 25226009
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials.
Stein Gold LF; Jarratt MT; Bucko AD; Grekin SK; Berlin JM; Bukhalo M; Weiss JS; Berk DR; Chang-Lin JE; Lin V; Kaoukhov A
J Drugs Dermatol; 2016 May; 15(5):553-61. PubMed ID: 27168264
[TBL] [Abstract][Full Text] [Related]
53. Investigation of the mechanism of action of 2% fusidic acid lotion in the treatment of acne vulgaris.
Sommer S; Bojar R; Cunliffe WJ; Holland D; Holland KT; Naags H
Clin Exp Dermatol; 1997 Sep; 22(5):211-5. PubMed ID: 9536540
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and Tolerability of a Fixed Combination of Clindamycin Phosphate (1.2%) and Benzoyl Peroxide (3.75%) Aqueous Gel in Moderate and Severe Acne Vulgaris Subpopulations.
Stein Gold L
J Drugs Dermatol; 2015 Sep; 14(9):969-74. PubMed ID: 26355615
[TBL] [Abstract][Full Text] [Related]
55. Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population.
Cook-Bolden FE; Weinkle SH; Guenin E; Bhatt V
J Drugs Dermatol; 2019 Jan; 18(1):32-38. PubMed ID: 30681791
[TBL] [Abstract][Full Text] [Related]
56. Clindamycin phosphate 1.2%-benzoyl peroxide (5% or 2.5%) plus tazarotene cream 0.1% for the treatment of acne.
Dhawan SS; Gwazdauskas J
Cutis; 2013 Feb; 91(2):99-104. PubMed ID: 23513559
[TBL] [Abstract][Full Text] [Related]
57. A comparison of Cleocin T 1 percent solution and Cleocin T 1 percent lotion in the treatment of acne vulgaris.
Goltz RW; Coryell GM; Schnieders JR; Neidert GL
Cutis; 1985 Sep; 36(3):265-8. PubMed ID: 2932307
[TBL] [Abstract][Full Text] [Related]
58. Comparative efficacy and safety results of two topical combination acne regimens.
Kircik LH
J Drugs Dermatol; 2009 Jul; 8(7):624-30. PubMed ID: 19588638
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
[TBL] [Abstract][Full Text] [Related]
60. Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
Maiti R; Sirka CS; Ashique Rahman MA; Srinivasan A; Parida S; Hota D
Clin Drug Investig; 2017 Nov; 37(11):1083-1091. PubMed ID: 28913735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
